FLSM
Frazier Life Sciences Management Portfolio holdings
AUM
$2.5B
This Quarter Return
-1.92%
1 Year Return
+52.94%
3 Year Return
+530.54%
5 Year Return
–
10 Year Return
–
AUM
$1.38B
AUM Growth
+$1.38B
(-14%)
Cap. Flow
-$62.1M
Cap. Flow
% of AUM
-4.5%
Top 10 Holdings %
Top 10 Hldgs %
65.28%
Holding
52
New
8
Increased
7
Reduced
4
Closed
3
Top Buys
| 1 |
BridgeBio Pharma
BBIO
|
$19.4M |
| 2 |
Revolution Medicines
RVMD
|
$18.5M |
| 3 |
Enliven Therapeutics
ELVN
|
$18.2M |
| 4 |
MacroGenics
MGNX
|
$12.2M |
| 5 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$8.06M |
Top Sells
| 1 |
IMGO
Imago BioSciences, Inc. Common stock
IMGO
|
$143M |
| 2 |
ALLK
Allakos
ALLK
|
$16.4M |
| 3 |
Krystal Biotech
KRYS
|
$4.35M |
| 4 |
Replimune Group
REPL
|
$4.32M |
| 5 |
ESSA Pharma
EPIX
|
$1.52M |
Sector Composition
| 1 | Healthcare | 99.93% |
